VIVS
VivoSim Labs, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.57M
P/E Ratio
0.90
EPS
$1.76
Beta
1.44
52W High
$5.30
52W Low
$1.25
50-Day MA
$1.92
200-Day MA
$2.20
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About VivoSim Labs, Inc.
VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | 142,000 |
| Gross Profit (TTM) | $-3.78M |
| EBITDA | $-11.22M |
| Operating Margin | -10577.00% |
| Return on Equity | -51.10% |
| Return on Assets | -132.50% |
| Revenue/Share (TTM) | $0.06 |
| Book Value | $1.70 |
| Price-to-Book | 0.97 |
| Price-to-Sales (TTM) | 32.21 |
| EV/Revenue | 4.17 |
| EV/EBITDA | -0.34 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 8.30% |
| Shares Outstanding | $2.89M |
| Float | $2.58M |
| % Insiders | 2.09% |
| % Institutions | 8.07% |
Data last updated: 4/9/2026